Spur Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
256
- Latest Deal Type
-
Buyout/LBO
- Latest Deal Amount
-
$50M
Spur Therapeutics General Information
Description
Developer of genetic therapies designed to address complex medical conditions. The company offers in vivo gene therapy research, therapeutic protein engineering, viral vector development and clinical-stage genetic medicine programs for debilitating chronic diseases, enabling patients and healthcare providers to access potential treatments that address underlying disease mechanisms and may reduce the need for ongoing therapy.
Contact Information
Website
www.spurtherapeutics.comCorporate Office
- Sycamore House
- Gunnels Wood Road
- Stevenage SG1 2BP
- England, United Kingdom
Corporate Office
- Sycamore House
- Gunnels Wood Road
- Stevenage SG1 2BP
- England, United Kingdom
Spur Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Buyout/LBO | 17-Jun-2024 | $50M | Completed | Clinical Trials - Phase 2 | ||
| 7. PIPE | 01-Mar-2022 | Completed | Clinical Trials - Phase 2 | |||
| 6. IPO | 07-Aug-2020 | Completed | Pre-Clinical Trials | |||
| 5. Later Stage VC (Series C) | 30-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC (Series B) | 19-Jun-2018 | Completed | Product Development | |||
| 3. Early Stage VC (Series A) | 11-Dec-2015 | Completed | Product Development | |||
| 2. Angel (individual) | 22-May-2015 | $17M | $17M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Spur Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series C | ||||||||
| Series A | 34,740,000 | $0.000013 | $1.25 | $1.25 | 1x | $1.25 | 28.3% |
Spur Therapeutics Patents
Spur Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202119033-D0 | Assay | Inactive | 24-Dec-2021 | ||
| GB-202119034-D0 | Polypeptide | Inactive | 24-Dec-2021 | ||
| WO-2023079301-A1 | Assays using mutant complement factor i variants with decreased activity | Inactive | 04-Nov-2021 | ||
| WO-2023079297-A1 | Mutant complement factor i variants with increased activity | Inactive | 04-Nov-2021 | ||
| GB-202109231-D0 | Promoter | Inactive | 25-Jun-2021 | C07K14/755 |
Spur Therapeutics Signals
Spur Therapeutics Acquisitions (1)
Spur Therapeutics’s most recent deal was a Merger/Acquisition with SwanBio Therapeutics. The deal was made on 25-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SwanBio Therapeutics | 25-Jun-2024 | Merger/Acquisition | Drug Discovery |
Spur Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SwanBio Therapeutics | Bala Cynwyd, PA | 2017 |
Spur Therapeutics FAQs
-
When was Spur Therapeutics founded?
Spur Therapeutics was founded in 2015.
-
Where is Spur Therapeutics headquartered?
Spur Therapeutics is headquartered in Stevenage, United Kingdom.
-
What is the size of Spur Therapeutics?
Spur Therapeutics has 256 total employees.
-
What industry is Spur Therapeutics in?
Spur Therapeutics’s primary industry is Drug Discovery.
-
Is Spur Therapeutics a private or public company?
Spur Therapeutics is a Private company.
-
What is the current valuation of Spur Therapeutics?
The current valuation of Spur Therapeutics is .
-
What is Spur Therapeutics’s current revenue?
The current revenue for Spur Therapeutics is .
-
How much funding has Spur Therapeutics raised over time?
Spur Therapeutics has raised $484M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process